Glow (GHK-Cu / BPC-157 / TB-500)

Muscle/RecoveryRegenerative-cosmetic blendExperimental

Vendor blend typically combining GHK-Cu, BPC-157, and TB-500 for cosmetic/regenerative research. Not a single API; BPC-157 and TB-500 are WADA issues if the blend contains them.

Calculate Dose

For research use only.

Key Facts

CAS: —
Molecular Weight (MW): Varies
Half-life: Varies by component
Unit: mg
Administration Route: Subcutaneous
Frequency: Daily
Last updated: 8/23/2026
Targets: Extracellular matrixAngiogenic pathways (component-dependent)

Overview

Vendor blend typically combining GHK-Cu, BPC-157, and TB-500 for cosmetic/regenerative research. Not a single API; BPC-157 and TB-500 are WADA issues if the blend contains them.

Protocol

Dosage Range: 1-2 mg total blend
Frequency: Daily
Cycle: 6-8 weeks on, 4 off
Administration Route: Subcutaneous
Reconstitution Guide: 5 mL BAC for 70 mg blend

Science

Mechanism of Action

Intended synergy of copper-peptide matrix remodeling (GHK-Cu) plus unapproved regenerative peptides. There is no pivotal trial of branded GLOW as a drug.